Chonluten 20mg

Chonluten 20 mg: research material

Buy Chonluten 20 mg for laboratory research, supplied as lyophilized powder in one boxed 3 mL vial.

Chonluten is a synthetic tripeptide associated with the EDG sequence: glutamic acid-aspartic acid-glycine. It has been studied in monocyte and macrophage cell-culture models.

Choose the material and presentation

The EDG sequence distinguishes Chonluten from Cartalax’s AED reference and from other short peptides that contain some of the same amino acids. Sequence order is part of the material identity.

The labeled 20 mg is the amount of dry material in the vial, not a solution concentration. Match the named peptide and any stated chemical form to the method you intend to use.

Chonluten in THP-1 cell research

A primary study compared Chonluten with four other peptide preparations in THP-1 cells, a human leukemia-derived monocyte cell line, and in macrophage-like cells differentiated from that line. The experiments included bacterial lipopolysaccharide (LPS) stimulation and measurements of cytokines and signaling pathways.

Responses depended on the cell state and conditions. Chonluten slightly increased TNF release in monocytes without LPS, while the peptide treatments reduced LPS-stimulated TNF and IL-6 in differentiated macrophage-like cells. The study also observed a modest apoptotic response with Chonluten.

These differences are lost in a blanket “anti-inflammatory” claim. They are cell-culture observations, not evidence that this material improves respiratory function or treats a human condition.

Original study

Product records and batch reports

Review available lot reports and product files in the product documentation section. Compare the product name, lot and identity information before interpreting purity or measured-content results.

A batch report documents the tested material. It does not establish biological activity in THP-1 cells or any other model; that requires an appropriate experiment with its own controls.